REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) Form 8-K — May 13, 2026

$RVPHForm 8-KItems 3.01, 8.01Filed May 13, 2026, 8:03 AM ET0001437749-26-016538Original filing

Reviva Pharmaceuticals Holdings, Inc. received notice from the Nasdaq Hearings Panel that its common stock will be delisted from The Nasdaq Capital Market due to non-compliance with the minimum bid price requirement of $1.00 per share. Trading on Nasdaq will be suspended as of the open of business on May 14, 2026.

Key figures

Otc Market Tier: OTCQB Venture Market
Otc Trading Start Date: May 14, 2026
Nasdaq Suspension Date: May 14, 2026
Minimum Bid Price Requirement: $1.00 per share

Price after filing

1 day: 0.0%7 days: 0.0%30 days: +94.2%

Close on the filing date to close N calendar days later (from $0.35). Historical, not a forecast.

AI analysis

Red flags4 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.